Quote:
Originally Posted by O.city
The mutations are happening in the actual spike protein. So if the protein structure is different, the current vaccines woudlnt' have efficacy as it's making immune cells that wouldn't recognize that spike.
|
They targeted many spots on the spike protein. Variants are a concern, but as long as antibodies target enough antigens on the spike protein, it will still work.
Vaccine can be updated quickly too.